Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia

Leukemia Research

Volumn 25, Issue 8, 2001, Pages 711-717

  Oliveira, Maria Regina ^b   Ohnuma, Lucia ^a   Bendit, Israel ^b   Dorlhiac Lacer, Pedro ^b   Giannella Neto, Daniel ^a  

^a Laboratory for Cellular and Molecular Endocrinology (LIM 25)   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic myelogenous leukemia; Flow cytometry; Insulin like growth factor I receptor; Interferon alpha; RT PCR

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CELL TYPE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOID CELL; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CHILD; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; HYDROXYUREA; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; MONOCYTES; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 0034997909     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00011-X     Document Type: Article

References (31)

1. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis
2. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells
3. A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis
4. The haematopoietic effects of growth hormone and insulin like growth factor I
5. Regulation of myeloid growth and differentiation by insulin-like growth factor 1 receptor
6. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells
7. Biology of disease: insulin-like growth factors receptors. Its role in cell proliferation, apoptosis and tumorogenicity
8. Growth, differentiation, and survival: multiple physiological functions of insulin-like growth factors
9. In vitro and in vivo effect of growth hormone on cytotoxic activity
10. Insulin-like growth factor 1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin
11. Expression of functional insulin-like growth factor I receptor on lymphoid cell subsets of rats
12. Prolonged survival in chronic myelogenous leukemia following cytogenetic response to alpha interferon therapy
13. Randomized comparison of interferon-α with bussulfan and hydroxyurea in chronic myelogenous leukemia
14. Clinical overview of alpha interferon
15. Insulin-like growth factor 1 receptors, IGF-I and IGF-2 are expressed in primary human sarcomas
16. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, eritrocyte, platelet and monocyte/macrophage
17. The biology of normal and neoplastic stem cells in CML
18. Overexpression of insulin-like growth factor receptor type-1 in T-cell lines infected with human T-lymphotropic virus types I and II
19. Growth promoting effects of insulin-like growth factor 1 on hematopoietic cells: overexpression of introduced IGF-IR abrogates interleukin-3 dependency of murine factor dependent cells by a ligand-dependent mechanism
20. Overexpression of the IGF-I receptor promotes ligand dependent neoplastic transformation
21. Chronic myelogenous leukemia: a review
22. Chronic myelogenous leukemia: a concise update
23. Management of chronic myeloid leukemia
24. Insulin-like growth factor I binds selectively to human peripheral blood monocytes and B-lymphocytes
25. Expression of functional insulin-like growth factor-1 receptor on lymphoid cells subsets of rats
26. Effects of interferon alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia
27. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia
28. Chronic myeloid leukemia as na immunological target
29. GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia
30. Clonal heterogeniety of dentritic cells derived from patients with chronic myeloid leukemia and enhancement of their T cells stimulatory activity by IFN-alpha